Histone Modifications and Cancer

James E. Audia(Therapeutics Clinical Research), Robert M. Campbell(Children's Health Queensland Hospital and Health Service)

Cold Spring Harbor Perspectives in Biology

April 1, 2016

10.1101/cshperspect.a019521

Cited by 1,062

Related Papers

The promise and peril of chemical probes

|Nature Chemical Biology|2015|848

Databases for Congenital Heart Defect Public Health Studies Across the Lifespan

|Journal of the American Heart Association|2016|33

A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer

|Investigational New Drugs|2019|30

A Blueprint for an International Cancer Epigenome Consortium. A Report from the AACR Cancer Epigenome Task Force

|Cancer Research|2012|25